Weight Loss :: Foods Improving Consumers Ability to Manage Calorie Intake Key to

The U.S. Food and Drug Administration (FDA) has received a report that could help American industry and consumers take important steps to successfully combat the nation’s obesity problem. The report is titled, the “Keystone Forum on Away-From-Home Foods: Opportunities for Preventing Weight Gain and Obesity.” It provides recommendations from experts in industry, government, civic sector organizations, and academia, for improving consumers’ ability to manage calorie intake from foods prepared and purchased away-from-home. The Keystone Report offers recommendations related to: 1) understanding and influencing consumer behavior; 2) increasing the availability of lower-calorie products, menu items, and meals; and 3) providing consumers with nutrition information.

HIV :: New Generic AIDS Drug for AIDS Relief

The Food and Drug Administration (FDA) today announced the tentative approval of generic abacavir (a-BAK-a-veer) sulfate tablets manufactured by Aurobindo Pharma LTD. of Hyderabad, India. Abacavir sulfate tablets are the first generic version of the already approved Ziagen Tablets, an anti-HIV medication manufactured by GlaxoSmithKline. This product will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief.

Skin Cancer :: Fatty diet doesn?t increase skin cancer risk

A new study that contradicts the results of a previous research has found that high fat intake does not increase the risk of certain types of skin cancer, and that it might even play a protective role in the development of non-melanoma skin cancer.

ADHD :: Amphetamine salts most effective for treating ADHD

Stimulant medications, such as mixed amphetamine salts (MAS) and methylphenidates are significantly more effective than nonstimulant ADHD medications or novel stimulants, such as modafinil, in the treatment of children with attention-deficit/hyperactivity disorder (ADHD).

Crohn?s Disease :: Remicade for Children with Crohn?s Disease

The Food and Drug Administration today approved Remicade (infliximab) to treat children with active Crohn’s disease, a chronic, inflammatory condition of the bowel that can be severely debilitating. Remicade is a genetically engineered monoclonal antibody, which reduces inflammation (swelling/redness) by blocking the action of tumor necrosis factor-alpha (TNF-a), that was initially approved in 1998 to treat Crohn’s disease in adults.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack